Literature DB >> 23010237

Successful treatment of exercise-induced anaphylaxis with omalizumab.

Sarah M Bray, Merritt L Fajt, Andrej A Petrov.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23010237     DOI: 10.1016/j.anai.2012.07.021

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  7 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Food-dependent exercise-induced anaphylaxis.

Authors:  Bryanne Minty
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

3.  Food-dependent exercise-induced anaphylaxis.

Authors:  Robert H Wauters; Taylor A Banks; Evelyn M Lomasney
Journal:  BMJ Case Rep       Date:  2018-04-11

Review 4.  Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors:  Jay A Lieberman; Mirna Chehade
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 5.  Exercise-induced Anaphylaxis: the Role of Cofactors.

Authors:  Dukagjin Zogaj; Alkerta Ibranji; Mehmet Hoxha
Journal:  Mater Sociomed       Date:  2014-12-14

6.  Omalizumab, an anti-immunoglobulin E antibody: state of the art.

Authors:  Cristoforo Incorvaia; Marina Mauro; Marina Russello; Chiara Formigoni; Gian Galeazzo Riario-Sforza; Erminia Ridolo
Journal:  Drug Des Devel Ther       Date:  2014-02-07       Impact factor: 4.162

7.  Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.

Authors:  Mark R Peterson; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.